ACAD logo

ACADIA Pharmaceuticals (ACAD) Free cash flow

annual FCF:

$157.20M+$180.54M(+773.27%)
December 31, 2024

Summary

  • As of today (June 19, 2025), ACAD annual free cash flow is $157.20 million, with the most recent change of +$180.54 million (+773.27%) on December 31, 2024.
  • During the last 3 years, ACAD annual FCF has risen by +$283.98 million (+223.99%).
  • ACAD annual FCF is now at all-time high.

Performance

ACAD Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADcash flow metrics

quarterly FCF:

-$78.52M-$118.44M(-296.64%)
March 31, 2025

Summary

  • As of today (June 19, 2025), ACAD quarterly free cash flow is -$78.52 million, with the most recent change of -$118.44 million (-296.64%) on March 31, 2025.
  • Over the past year, ACAD quarterly FCF has dropped by -$107.59 million (-370.01%).
  • ACAD quarterly FCF is now -191.95% below its all-time high of $85.39 million, reached on December 31, 2023.

Performance

ACAD quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADcash flow metrics

TTM FCF:

$49.60M-$107.59M(-68.45%)
March 31, 2025

Summary

  • As of today (June 19, 2025), ACAD TTM free cash flow is $49.60 million, with the most recent change of -$107.59 million (-68.45%) on March 31, 2025.
  • Over the past year, ACAD TTM FCF has increased by +$25.94 million (+109.61%).
  • ACAD TTM FCF is now -75.52% below its all-time high of $202.66 million, reached on September 30, 2024.

Performance

ACAD TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

ACAD Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+773.3%-370.0%+109.6%
3 y3 years+224.0%-2.9%+135.0%
5 y5 years+203.2%-57.2%+136.2%

ACAD Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+224.0%-191.9%at low-75.5%+135.0%
5 y5-yearat high+203.2%-191.9%at low-75.5%+132.0%
alltimeall timeat high+171.9%-191.9%at low-75.5%+119.8%

ACAD Free cash flow History

DateAnnualQuarterlyTTM
Mar 2025
-
-$78.52M(-296.6%)
$49.60M(-68.4%)
Dec 2024
$157.20M(-773.3%)
$39.93M(-36.8%)
$157.20M(-22.4%)
Sep 2024
-
$63.18M(+152.6%)
$202.66M(+151.8%)
Jun 2024
-
$25.01M(-14.0%)
$80.48M(+240.1%)
Mar 2024
-
$29.08M(-65.9%)
$23.66M(-201.4%)
Dec 2023
-$23.35M(-79.5%)
$85.39M(-244.7%)
-$23.35M(-82.4%)
Sep 2023
-
-$59.01M(+85.6%)
-$132.59M(+78.4%)
Jun 2023
-
-$31.80M(+77.3%)
-$74.31M(+33.6%)
Mar 2023
-
-$17.93M(-24.8%)
-$55.64M(-51.2%)
Dec 2022
-$114.03M(-10.1%)
-$23.85M(+3181.2%)
-$114.03M(+0.6%)
Sep 2022
-
-$727.00K(-94.5%)
-$113.30M(-12.6%)
Jun 2022
-
-$13.13M(-82.8%)
-$129.64M(-8.6%)
Mar 2022
-
-$76.33M(+230.1%)
-$141.89M(+11.9%)
Dec 2021
-$126.78M(-11.8%)
-$23.12M(+35.5%)
-$126.78M(-4.8%)
Sep 2021
-
-$17.06M(-32.7%)
-$133.15M(-5.3%)
Jun 2021
-
-$25.37M(-58.6%)
-$140.60M(-9.3%)
Mar 2021
-
-$61.23M(+107.6%)
-$155.04M(+7.9%)
Dec 2020
-$143.75M(-5.6%)
-$29.49M(+20.3%)
-$143.75M(-0.3%)
Sep 2020
-
-$24.51M(-38.4%)
-$144.18M(+4.0%)
Jun 2020
-
-$39.82M(-20.3%)
-$138.60M(+1.0%)
Mar 2020
-
-$49.94M(+66.9%)
-$137.20M(-9.9%)
Dec 2019
-$152.26M(-10.2%)
-$29.91M(+58.0%)
-$152.26M(-6.0%)
Sep 2019
-
-$18.93M(-50.7%)
-$161.95M(-13.1%)
Jun 2019
-
-$38.42M(-40.9%)
-$186.31M(-1.4%)
Mar 2019
-
-$65.00M(+64.1%)
-$188.89M(+11.4%)
Dec 2018
-$169.57M(-22.4%)
-$39.60M(-8.5%)
-$169.57M(+6.1%)
Sep 2018
-
-$43.30M(+5.6%)
-$159.87M(-8.7%)
Jun 2018
-
-$40.99M(-10.3%)
-$175.03M(-9.4%)
Mar 2018
-
-$45.68M(+52.8%)
-$193.21M(-11.6%)
Dec 2017
-$218.57M(+0.3%)
-$29.90M(-48.8%)
-$218.57M(-12.6%)
Sep 2017
-
-$58.46M(-1.2%)
-$250.10M(+3.6%)
Jun 2017
-
-$59.16M(-16.7%)
-$241.38M(-2.5%)
Mar 2017
-
-$71.05M(+15.6%)
-$247.54M(+13.6%)
Dec 2016
-$217.91M(+75.8%)
-$61.44M(+23.5%)
-$217.91M(+13.8%)
Sep 2016
-
-$49.73M(-23.9%)
-$191.49M(+10.2%)
Jun 2016
-
-$65.33M(+57.7%)
-$173.80M(+25.0%)
Mar 2016
-
-$41.42M(+18.3%)
-$139.02M(+12.2%)
Dec 2015
-$123.94M(+86.1%)
-$35.02M(+9.3%)
-$123.94M(+16.0%)
Sep 2015
-
-$32.04M(+4.9%)
-$106.82M(+15.7%)
Jun 2015
-
-$30.55M(+16.0%)
-$92.34M(+17.2%)
Mar 2015
-
-$26.33M(+47.2%)
-$78.76M(+18.2%)
Dec 2014
-$66.61M
-$17.89M(+1.9%)
-$66.61M(+12.7%)
Sep 2014
-
-$17.56M(+3.5%)
-$59.11M(+14.9%)
Jun 2014
-
-$16.97M(+19.6%)
-$51.44M(+28.6%)
DateAnnualQuarterlyTTM
Mar 2014
-
-$14.19M(+36.5%)
-$39.99M(+23.5%)
Dec 2013
-$32.39M(+49.7%)
-$10.39M(+5.1%)
-$32.39M(+14.5%)
Sep 2013
-
-$9.89M(+79.2%)
-$28.29M(+19.3%)
Jun 2013
-
-$5.52M(-16.2%)
-$23.71M(+3.1%)
Mar 2013
-
-$6.58M(+4.6%)
-$22.99M(+6.3%)
Dec 2012
-$21.63M(+8.7%)
-$6.30M(+18.7%)
-$21.63M(+4.6%)
Sep 2012
-
-$5.31M(+10.5%)
-$20.67M(+5.8%)
Jun 2012
-
-$4.80M(-8.2%)
-$19.54M(-2.4%)
Mar 2012
-
-$5.23M(-2.0%)
-$20.02M(+0.6%)
Dec 2011
-$19.90M(+85.9%)
-$5.34M(+27.9%)
-$19.90M(+99.8%)
Sep 2011
-
-$4.17M(-20.9%)
-$9.96M(+19.9%)
Jun 2011
-
-$5.28M(+3.4%)
-$8.30M(-11.3%)
Mar 2011
-
-$5.11M(-210.9%)
-$9.36M(-12.6%)
Dec 2010
-$10.70M(-22.3%)
$4.60M(-282.6%)
-$10.70M(-55.6%)
Sep 2010
-
-$2.52M(-60.2%)
-$24.10M(-27.5%)
Jun 2010
-
-$6.33M(-1.8%)
-$33.25M(+380.0%)
Mar 2010
-
-$6.45M(-26.6%)
-$6.93M(-49.7%)
Dec 2009
-$13.77M(-78.8%)
-$8.79M(-24.7%)
-$13.77M(-20.2%)
Sep 2009
-
-$11.68M(-158.4%)
-$17.26M(-19.7%)
Jun 2009
-
$19.99M(-250.4%)
-$21.49M(-62.8%)
Mar 2009
-
-$13.29M(+8.3%)
-$57.76M(-11.3%)
Dec 2008
-$65.09M(+17.6%)
-$12.28M(-22.8%)
-$65.09M(-2.5%)
Sep 2008
-
-$15.91M(-2.3%)
-$66.75M(+4.1%)
Jun 2008
-
-$16.28M(-21.1%)
-$64.14M(+4.0%)
Mar 2008
-
-$20.62M(+48.0%)
-$61.67M(+11.4%)
Dec 2007
-$55.34M(+27.4%)
-$13.93M(+4.8%)
-$55.34M(+1.3%)
Sep 2007
-
-$13.30M(-3.8%)
-$54.63M(+1.4%)
Jun 2007
-
-$13.82M(-3.3%)
-$53.86M(+8.6%)
Mar 2007
-
-$14.29M(+8.1%)
-$49.57M(+14.1%)
Dec 2006
-$43.44M(+104.1%)
-$13.22M(+5.5%)
-$43.44M(+15.9%)
Sep 2006
-
-$12.53M(+31.4%)
-$37.49M(+18.9%)
Jun 2006
-
-$9.53M(+16.8%)
-$31.54M(+8.4%)
Mar 2006
-
-$8.16M(+12.4%)
-$29.09M(+36.7%)
Dec 2005
-$21.29M(+0.0%)
-$7.26M(+10.5%)
-$21.29M(+1.7%)
Sep 2005
-
-$6.58M(-7.2%)
-$20.92M(+6.7%)
Jun 2005
-
-$7.08M(+1873.5%)
-$19.62M(+10.9%)
Mar 2005
-
-$359.00K(-94.8%)
-$17.69M(-16.9%)
Dec 2004
-$21.28M(+83.5%)
-$6.90M(+31.0%)
-$21.28M(+48.0%)
Sep 2004
-
-$5.27M(+2.2%)
-$14.38M(+57.9%)
Jun 2004
-
-$5.16M(+30.8%)
-$9.10M(+130.8%)
Mar 2004
-
-$3.94M
-$3.94M
Dec 2003
-$11.59M(+20.5%)
-
-
Dec 2002
-$9.62M(-138.0%)
-
-
Dec 2000
$25.33M
-
-

FAQ

  • What is ACADIA Pharmaceuticals annual free cash flow?
  • What is the all time high annual FCF for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals annual FCF year-on-year change?
  • What is ACADIA Pharmaceuticals quarterly free cash flow?
  • What is the all time high quarterly FCF for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals quarterly FCF year-on-year change?
  • What is ACADIA Pharmaceuticals TTM free cash flow?
  • What is the all time high TTM FCF for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals TTM FCF year-on-year change?

What is ACADIA Pharmaceuticals annual free cash flow?

The current annual FCF of ACAD is $157.20M

What is the all time high annual FCF for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high annual free cash flow is $157.20M

What is ACADIA Pharmaceuticals annual FCF year-on-year change?

Over the past year, ACAD annual free cash flow has changed by +$180.54M (+773.27%)

What is ACADIA Pharmaceuticals quarterly free cash flow?

The current quarterly FCF of ACAD is -$78.52M

What is the all time high quarterly FCF for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high quarterly free cash flow is $85.39M

What is ACADIA Pharmaceuticals quarterly FCF year-on-year change?

Over the past year, ACAD quarterly free cash flow has changed by -$107.59M (-370.01%)

What is ACADIA Pharmaceuticals TTM free cash flow?

The current TTM FCF of ACAD is $49.60M

What is the all time high TTM FCF for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high TTM free cash flow is $202.66M

What is ACADIA Pharmaceuticals TTM FCF year-on-year change?

Over the past year, ACAD TTM free cash flow has changed by +$25.94M (+109.61%)
On this page